Track Bal Pharma Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Bal Pharma Limited BALPHARMA.NS · Stock Open Bal Pharma Limited in new tab

105.74 INR
P/E
23.62
EPS
4.53
Yield
1.11%
Safety Score
25
P/B
2.07
ROE
7.92
Beta
0.45
Loading chart...
Key Metrics
P/E23.62
EPS4.53
Book Value51.71
Price to Book2.07
Debt/Equity193.94
% Insiders65.279%
Growth
Revenue Growth0.35%
Earnings Growth4.46%
Dividend
Dividend Yield1.11%
Annual dividends1.20 INR
Ex-Div. DateSept. 17, 2026
5y avg Yield1.49%

DCF Valuation

Tweak assumptions to recompute fair value for Bal Pharma Limited (BALPHARMA.NS)
Currency: INR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Bal Pharma Limited Logo Bal Pharma Limited Analysis (BALPHARMA.NS)

India Health Care Official Website Stock

Is Bal Pharma Limited a good investment? Bal Pharma Limited (BALPHARMA.NS) is currently trading at 105.74 INR.

In terms of valuation, the stock trades at a P/E ratio of 23.62. This valuation is generally in line with the broader market.

For income investors, Bal Pharma Limited pays a dividend yield of 1.11%.

Investor FAQ

Does Bal Pharma Limited pay a dividend?

Yes, it pays an annual dividend of 1.20 INR (1.11% yield).

What asset class is Bal Pharma Limited?

Bal Pharma Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Bal Pharma Limited, together with its subsidiaries, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk drugs. It also provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostate enlargement, renal calculi, male infertility, and women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; anti-hypertensive, anti-lipidemic, and anti-obese products; skin care and bone health products; herbal liver protective and antioxidant; and cardiac care products under the Secremet and Servace brands. In addition, the company offers a range of APIs for therapeutic areas, such as anti-histamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, and acne treatment, etc.; and various formulations, including tablets, capsules, syrups, suspensions, ophthalmic, creams, and ointments. Further, it engages in the treatment of gastrointestinal disorders; and piles, fistula, and constipation. The company exports its products. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.

Exchange Ticker
NSI (India) BALPHARMA.NS
Trades
Dividend Yield
1.11%
5y avg 1.49%
Annual Dividends
1.20INR
Next Ex. Div Date
Sept. 17, 2026
Dividend History paid per year (INR)
Historical Dividends
Year Total Dividends
▸2026
1.20 INR
Oct. 24, 2026 1.2000
▸2025
1.20 INR
Oct. 25, 2025 1.2000
▸2024
1.20 INR
Oct. 25, 2024 1.2000
▸2023
1.00 INR
Oct. 25, 2023 1.0000
▸2022
1.00 INR
Oct. 19, 2022 1.0000
▸2021
1.00 INR
Oct. 24, 2021 1.0000
▸2019
1.00 INR
Oct. 23, 2019 1.0000
▸2018
1.00 INR
Oct. 22, 2018 1.0000
▸2017
1.00 INR
Oct. 22, 2017 1.0000
▸2016
1.00 INR
Oct. 22, 2016 1.0000
▸2015
1.00 INR
Oct. 22, 2015 1.0000
▸2014
1.00 INR
Sept. 12, 2014 1.0000
▸2013
0.75 INR
Oct. 18, 2013 0.7500
▸2009
0.75 INR
Nov. 1, 2009 0.7500
▸2008
1.00 INR
Oct. 1, 2008 1.0000
▸2007
0.75 INR
Sept. 7, 2007 0.7500
▸2006
0.75 INR
Sept. 7, 2006 0.7500
Upcoming Dividends
Name Payment Date Status Amount
Bal Pharma Limited Oct 24, 2026 Upcoming 1.2 INR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion